Transdel Pharmaceuticals Reports Second Quarter and Year-to-Date 2010 Results
Transdel Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced financial results for the three and six months ended June 30, 2010 and other activity during the second quarter. Â
cellulean Cellulite cream – cellulean Free Trial


Tags: , , , , ,